CLINICAL_TRIALS
ClinicalTrials.gov record update
Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT06498167
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-25T22:26:23.006737+00:00
- Published At
- 2024-07-15T00:00:00+00:00
- Record Updated At
- 2024-07-15
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Inflammatory Disease", "Drug Side Effect", "Drug Use", "Adverse Drug Event", "Adverse Drug Reaction", "Safety Issues"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-07-15"- protocolSection.identificationModule.nctId
"NCT06498167"- protocolSection.identificationModule.officialTitle
"Active Pharmacovigilance Study of the Medicine Rinvoq\u2122 (Upadacitinib)"- protocolSection.statusModule.overallStatus
"RECRUITING"- protocolSection.designModule.phases
[]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.